[ET Net News Agency, 30 September 2026] HANSOH PHARMA (03692) rose 5% to HK$35.2.
It hits an intra-day high of HK$35.2, breaking above the 250-D SMA of HK$35.117, and an intra-day low of HK$33.2. The total shares traded was 6.08 million, with a value of HK$208.67m. The active buy/sell ratio is 67:33, with net buying turnover of HK$61.91m. DAIWA CAPITAL MARKETS HK accounts for greatest net responsive buying turnover of HK$5.73m, with volume weighted average price of HK$34.124. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$22.39m, with volume weighted average price of HK$34.39. The stock has risen a combined 5.4% over the past 2 consecutive trading days.
The Hang Seng Index now rose 29 points, or 0.1% to 24,553; the Hang Seng China Enterprises Index now rose 24 points, or 0.3% to 8,202.
Basic Information| Nominal | 35.200 | % Chg | +5.01% |
| High | 35.200 | Low | 33.200 |
| Shares Tr | 6.08m | Turnover | 208.67m |
| 10-D SMA | 34.312 | %H.V | 36.262 |
| 20-D SMA | 34.401 | VWAP | 34.320 |
| 50-D SMA | 33.484 | RSI14 | 56.544 |
Status: Breaking above the 250-D SMA, active buy/sell ratio is 67:33, with net buying turnover of HK$61.91m, rising a combined 5.4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 35.200 | +5.01 |
| SIHUAN PHARM (00460) | 0.730 | +1.39 |
| GRAND PHARMA (00512) | 4.950 | +2.06 |
| SBP GROUP (01177) | 5.745 | +3.51 |
| HENGRUI PHARMA (01276) | 48.940 | +7.32 |
| LIVZON PHARMA (01513) | 22.900 | +4.38 |
| LUYE PHARMA (02186) | 1.885 | +3.29 |
| FOSUN PHARMA (02196) | 18.320 | +2.52 |
| SH PHARMA (02607) | 10.970 | +0.83 |
| CHINARES PHARMA (03320) | 4.455 | +2.18 |
(ed)
Nominal 
